Here are Friday's biggest analyst calls: Nvidia, SpaceX, Tesla, Apple, Mobileye, EchoStar, Toll Brothers & more
Here are Friday’s biggest calls on Wall Street: UBS reiterates Apple as neutral UBS said its checks show iPhone wait times are flat for Apple. “UBS Evidence Lab data that tracks iPhone availability across 30+ geographies indicates that average wait times were shorter by ~4 days YoY for the Pro and relatively flattish for the Pro Max.” Morgan Stanley reiterates Tesla as equal weight The firm said it is getting more “constructive” ahead of Tesla earnings. “Energy remains an underappreciated business, with integrated storage, solar, and compute driving Tesla as an integrated distributed compute and power provider.” JPMorgan initiates Praxis Precision Medicines as overweight JPMorgan called the company “unique.” “We are initiating coverage of Praxis Precision Medicines (PRAX) with an Overweight rating and a Dec 2027 price target of $700.” StoneX initiates Toll Brothers as buy StoneX said the homebuilder is well positioned despite the housing uncertainty. “We Initiate TOL With a Buy Rating and Price Target of $165 Per Share.” William Blair initiates Revolution Medicines as outperform The firm said Revolution is in a “dominant position.” “We are initiating coverage of Revolution Medicines with an Outperform rating and a DCF- based valuation of $226 per share.” Macquarie initiates Intuitive Machines as outperform Macquarie said it likes the company’s balance sheet. “LUNR offers exposure to increasing investment in recurring space operations and services, supported by a broad range of capabilities which has enabled its transformation into a vertically integrated space prime, while also supported by a net cash balance sheet.” Roth upgrades Avino Silver to buy from hold Roth said shares have plenty of upside. “We are upgrading ASM f rom Neutral to Buy while lowering our price target from $8.00 to $7.00.” Goldman Sachs initiates Elanco and Idexx Laboratories as buy Goldman said both animal health companies are compelling. “I DXX (Buy): High-quality compounder with proven execution track record. … . ELAN (Buy): Innovation-driven turnaround story where we believe the market under-appreciates the runway for growth from recent product cycles…” Piper Sandler initiates iRhythm as overweight Piper said investors should buy the dip. “We are initiating coverage of iRhythm (Nasdaq: IRTC) with an Overweight rating and $160 PT, which ascribes a ~4.5x EV/Sales multiple to our ’28E sales estimate.” Evercore ISI reiterates Nvidia as buy Evercore said it’s sticking with the stock. “We are buyers of NVDA. NVDA has underperformed SPX recently, which we attribute to 3 concerns: 1) DeepSeek lowers AI demand; 2) DeepSeek shifts AI compute-cycles away from NVDA; and 3) Blackwell delays. Our channel checks dispute the concerns.” Needham initiates Victoria’s Secret as buy Needham said it is bullish on the company’s turnaround. “We are initiating coverage of VSXY with a Buy rating and $106 PT.” Goldman Sachs upgrades Zeta Global to buy from neutral Goldman said it has better visibility. ” ZETA shares are up 65% YTD, but we expect upside to numbers could drive continued outperformance and we see a compelling 4x risk/reward skew.” Citi initiates Mobileye as buy Citi said the company is best positioned for autonomous driving. “Autonomous driving begins with vision, and Mobileye is the global leader with vehicle vision solutions. We are initiating coverage on MBLY with a Buy rating and a $11 price target.” Read more. Jefferies initiates Concentra as buy Jefferies said shares have more room to run. “CON is a high-quality compounder with differentiated ROIC (11-13% v. peer avg at 6-9%), a structurally advantaged payor mix that improves its risk profile, and a dominant position in the Occupational Health industry.” Evercore ISI reiterates SpaceX as outperform Evercore raised its price target to $275 per share from $230. “We expec t SPCX’s 3 Q26 print to be judged less on the quarter (where we’re ahead of the Street on revenue/EBITDA) than on five debates that should drive medium-term estimates and sentiment through year-end and into 2027.” Read more. DA Davidson upgrades Martin Marietta Materials to buy from neutral DA said investors should buy the weakness. “We are upgrading MLM t o BUY, $610 PT.” JPMorgan upgrades EchoStar to overweight from underweight The firm reinstated coverage and says EchoStar shares are attractive. “Following a period of restriction, we are moving to an Overweight rating and a December 2027 price target of $144 from a Not Rated designation.” Raymond James upgrades Greif to outperform from market perform Raymond James said the company is a “self-help story.” “We are upgrading GEF from Market Perform to Outperform. Regardless of volumes (which we continue to expect will be weak) Greif’s self-help playbook continues to drive margin expansion.” Raymond James upgrades Capri to strong buy from outperform Raymond James said Capri shares are compelling. “Upgrade to Strong Buy from Outperform on favorable setup.” Morgan Stanley upgrades Moog to overweight from equal weight Morgan Stanley said it sees earnings growth. “We upgrade Moog t o OW from EW as we see cons. underestimating growth / earnings into next year. FY27 guide and Dec. investor day present catalysts.” Bank of America upgrades Fox to buy from underperform Bank of America said it’s bullish on the Roku acquisition. “We upgrade Fox to Buy from Underperform and raise our PO to $85 from $54, now reflecting ~10x our CY28E updated pro forma EV/EBITDA, as we believe the risk/reward has shifted following the pending Roku acquisition.” Northland upgrades Semtech to outperform from market perform Northland said the risk/reward is now more attractive. “We downgraded SMTC last week, as the share price exceeded our PT. Shares declined 24% in a week. We now believe the risk-reward and valuation are more favorable.” Goldman Sachs reiterates Microsoft as buy The firm said it’s bullish ahead of earnings. “We think Microsoft i s the best positioned name in our Software coverage (also on CL) to benefit from compounding AI product cycles.” Raymond James upgrades Brinker to strong buy from outperform Raymond James said the owner of Brands like Chili’s is firing on all cylinders. “We are upgrading EAT t o Strong Buy from Outperform as we 1) expect a strong beat/raise and are confident in our above-consensus estimates, 2) see tangible levers to sustain MSD%+ comp growth (menu, marketing, ops)…”
